Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diagnostics - search results
If you're not happy with the results, please do another search
Who will pay for the precision cancer medicine revolution?
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Ketil Widerberg – Oslo Cancer Cluster
Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster and Chairman of Oslo Cancer Cluster Incubator
Widerberg builds on a long experience in realising new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.
Widerberg has broad operational experience ranging...
A new generation of testing for cancer: tools for navigating data in clinical decision...
Utilising early cancer detection: Are we getting the most out of first order tests for symptomatic cancer patients?
Multiple sclerosis facts & trends
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, walks us through multiple sclerosis facts & trends.
Beating lung cancer with the AI edge
Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.
Novacyt is powering ahead and tackling emerging health concerns
Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
ScanBox: Thinking inside the box for NHS diagnostic services
NHS diagnostic services have been placed under immense pressure by the COVID-19 pandemic, now, Fairford Medical’s CT ScanBoxes can ease up resource burdens
Using AI to support decision making & transform outcomes for stroke patients
Adam Nickerson, Head of Category, Digital and IT procurement frameworks at NHS Shared Business Services (NHS SBS), explains how artificial intelligence software (AI) is used to support decision making & transform outcomes for stroke patients.
What we need to make breakthroughs in dementia research
David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.
WHO licensing agreement can improve access to COVID health technologies
The WHO licensing agreement with the Medicines Patent Pool (MPP) and US National Institutes of Health (NIH) should improve access to some COVID health technologies, like early-stage vaccines and diagnostic tools.
Are Community Diagnostic Hubs the way forward?
Medispace, a provider of fully equipped MRI trailers and CT trailers, looks to the future of community diagnostic hubs, advocating for much-needed changes to be implemented.
Can predictive genomics make our healthcare systems more sustainable?
Dr Zisis Kozlakidis with Francesco Florindi, discuss predictive genomics and ask if it can help make our healthcare systems more sustainable.
European innovation potential knows no bounds
Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth, calls attention to building a pan-European innovation potential ecosystem in health served with top-notch infrastructures.
Understanding the immune system to create new malaria treatments
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
Fighting against a Covid tide to deliver cancer referral innovation
PinPoint Data Science is working with the NHS to deliver much needed innovation in cancer referral pathways
Innovative automation supports laboratory testing workflow
Global clinical diagnostics company Novacyt introduce a new automated liquid handling system to meet growing demand for no manual pipetting in COVID-19 PCR testing.
Examining the burden of rare diseases in the US
Open Access Government explore the research efforts of the U.S. National Institutes of Health to mitigate the often-underestimated burden of rare diseases on patients and their families.
Therapeutic feline and canine cancer vaccine
Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.
The global cost of visual impairment
250 million people suffer from visual impairment at a global cost of $3 trillion, Translational Imaging Innovations explain.
Removing the blindfold on antimicrobial resistance
Here, several academic experts explain what we need to know about removing the blindfold on antimicrobial resistance - by strengthening clinical microbiology laboratories in resource-limited settings.
